Sign in
4

Changes in Ownership

Lantern Pharma Inc. Filed Acc 0001493152-24-028182

Options or other derivatives

  • Chief Scientific Officer acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bhatia Kishor G. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-07-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +35,000 35,000 D
Loading xslF345X05/ownership.xml…